Stsp-0601 For
Hemophilia
Jiangsu BioJeTay Biotechnology Co., Ltd.Phase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 65/ 100
- Competitive Position
- 81/ 100
Competitive context
17 Active assets in the Hemophilia cohort.
View all 34 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →